Bellmunt, J <br/><br/>
Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Aug 2008 
 - 1387-1392 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdn066  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Renal Cell--drug therapy<br/>Female<br/>Humans<br/>Interferon-alpha--adverse effects<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Sirolimus--adverse effects